BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 457790)

  • 1. Expression of malignancy in hybrids between normal and malignant cells.
    Croce CM; Barrick J; Linnenbach A; Koprowski H
    J Cell Physiol; 1979 Jun; 99(3):279-85. PubMed ID: 457790
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tumorigenicity of human HT1080 fibrosarcoma X normal fibroblast hybrids: chromosome dosage dependency.
    Benedict WF; Weissman BE; Mark C; Stanbridge EJ
    Cancer Res; 1984 Aug; 44(8):3471-9. PubMed ID: 6744274
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Suggestive evidence for functionally distinct, tumor-suppressor genes on chromosomes 1 and 11 for a human fibrosarcoma cell line, HT1080.
    Kugoh HM; Hashiba H; Shimizu M; Oshimura M
    Oncogene; 1990 Nov; 5(11):1637-44. PubMed ID: 2267132
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetic analysis of transformed and malignant phenotypes in somatic cell hybrids between tumorigenic Chinese hamster cells and diploid mouse fibroblasts.
    Schäfer R; Doehmer J; Drüge PM; Rademacher I; Willecke K
    Cancer Res; 1981 Mar; 41(3):1214-21. PubMed ID: 7459862
    [No Abstract]   [Full Text] [Related]  

  • 5. Deletion of p16INK4A/CDKN2 and p15INK4B in human somatic cell hybrids and hybrid-derived tumors.
    Kuerbitz SJ; Malandro J; Compitello N; Baylin SB; Graff JR
    Cell Growth Differ; 1999 Jan; 10(1):27-33. PubMed ID: 9950215
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Expression of malignancy traits in the interspecific somatic hybrids of tumor and normal cells].
    Kakpakova ES
    Genetika; 1983 Nov; 19(11):1845-50. PubMed ID: 6317520
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of collagenase IV (basement membrane collagenase) activity in murine tumor cell hybrids that differ in metastatic potential.
    Turpeenniemi-Hujanen T; Thorgeirsson UP; Hart IR; Grant SS; Liotta LA
    J Natl Cancer Inst; 1985 Jul; 75(1):99-103. PubMed ID: 2989606
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Suppression of tumorigenicity in hybrids of tumorigenic Chinese hamster cells and diploid mouse fibroblasts: dependence on the presence of at least three different mouse chromosomes and independence of hamster genome dosage.
    Schäfer R; Hoffmann H; Willecke K
    Cancer Res; 1983 May; 43(5):2240-6. PubMed ID: 6831446
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Suppression of tumorigenicity in somatic cell hybrids. II. Human chromosomes implicated as suppressors of tumorigenicity in hybrids with Chinese hamster ovary cells.
    Klinger HP; Shows TB
    J Natl Cancer Inst; 1983 Sep; 71(3):559-69. PubMed ID: 6577230
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Suppression of malignancy in human lung cancer (A549/8) times mouse fibroblast (3T3-4E) somatic cell hybrids.
    Carney DN; Edgell CJ; Gazdar AF; Minna JD
    J Natl Cancer Inst; 1979 Feb; 62(2):411-5. PubMed ID: 283273
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Some ultrastructural features of the cell surface after SV40 transformation and somatic hybridization with normal untransformed cells.
    Kilarski W
    Cancer Res; 1975 Oct; 35(10):2797-807. PubMed ID: 168969
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Transmission and expression of malignancy in somatic hybrid cell lines (hamster/hamster, mouse/mouse, hamster/mouse)].
    Berebbi M
    Bull Cancer; 1976; 63(2):145-73. PubMed ID: 186142
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of the N-ras oncogene in tumorigenic and non-tumorigenic HT 1080 fibrosarcoma X normal human fibroblast hybrid cells.
    Weissman BE; Mark CS; Benedict WF; Stanbridge EJ
    Prog Clin Biol Res; 1985; 175():141-9. PubMed ID: 3887427
    [No Abstract]   [Full Text] [Related]  

  • 14. Multiple features of advanced melanoma recapitulated in tumorigenic variants of early stage (radial growth phase) human melanoma cell lines: evidence for a dominant phenotype.
    Bani MR; Rak J; Adachi D; Wiltshire R; Trent JM; Kerbel RS; Ben-David Y
    Cancer Res; 1996 Jul; 56(13):3075-86. PubMed ID: 8674065
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of S100P protein correlates with and contributes to the tumorigenic capacity of HeLa cervical carcinoma cells.
    Gibadulinová A; Baráthová M; Kopácek J; Hulíková A; Pastoreková S; Kettmann R; Pastorek J
    Oncol Rep; 2005 Aug; 14(2):575-82. PubMed ID: 16012747
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Primary transfection as a mechanism for transformation of host cells by human tumor cells implanted in nude mice.
    Gupta V; Rajaraman S; Gadson P; Costanzi JJ
    Cancer Res; 1987 Oct; 47(19):5194-201. PubMed ID: 3621205
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stable nontumorigenic phenotype of somatic cell hybrids between malignant Burkitt's lymphoma cells and autologous EBV-immortalized B cells despite induction of chromosomal breakage and loss.
    Jox A; Taquia E; Vockerodt M; Draube A; Pawlita M; Möller P; Bullerdiek J; Diehl V; Wolf J
    Cancer Res; 1998 Nov; 58(21):4930-9. PubMed ID: 9810002
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Selective incorporation of fibronectin isoforms into the extracellular matrix of hybrids between human fibrosarcoma cells and normal human fibroblasts.
    Devlin J; Harris H
    Exp Cell Res; 1994 Sep; 214(1):429-32. PubMed ID: 8082745
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transformation of mouse cells by fusion with chronic granulocytic leukemia cells: possible role of human chromosome.
    Engel E; McGee BJ; Russell MH; Cassidy PS; Flexner JM; Engel-de-Montmollin ML
    Ann Genet; 1976 Dec; 19(4):249-52. PubMed ID: 1087854
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Alpha 6 integrin is up-regulated in step increments accompanying neoplastic transformation and tumorigenic conversion of human fibroblasts.
    Lin CS; Zhang K; Kramer R
    Cancer Res; 1993 Jul; 53(13):2950-3. PubMed ID: 7686445
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.